Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Wattacheril

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Gastroenterology Clinics of North America|February 9, 2020
Extrahepatic Manifestations of Nonalcoholic Fatty Liver DiseaseJulia Wattacheril
Hepatology (Baltimore, Md.)|October 6, 2012
Nonalcoholic fatty liver disease (NAFLD): is it really a serious condition?Julia Wattacheril, Naga Chalasani
Frontline Gastroenterology|October 26, 2020
Non-alcoholic fatty liver disease (NAFLD) in non-obese individualsMeaghan Phipps, Julia Wattacheril
Clinical Liver Disease|June 13, 2019
Management of nonalcoholic fatty liver disease: Role of bariatric surgeryJulia Wattacheril, Naga Chalasani
The American Journal of Gastroenterology|February 4, 2021
Response to BraillonMeaghan Phipps, Julia Wattacheril,
Clinical Liver Disease|July 24, 2019
Julia Wattacheril, Naga Chalasani
Current Hepatology Reports|September 27, 2016
Lean NAFLD: An Underrecognized OutlierJulia Wattacheril, Arun J Sanyal
Annual Review of Pharmacology and Toxicology|October 24, 2017
Nonalcoholic Steatohepatitis (NASH) and Hepatic Fibrosis: Emerging TherapiesJulia Wattacheril, Danny Issa, Arun Sanyal
Clinical Liver Disease|June 17, 2021
Health Disparities in Screening, Diagnosis, and Treatment of Hepatocellular CarcinomaAverill Guo, Sydney Pomenti, Julia Wattacheril
Expert Opinion on Drug Safety|June 23, 2017
Treatment options for nonalcoholic steatohepatitis - a safety evaluationDanny Issa, Julia Wattacheril, Arun J Sanyal
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Gastroenterology Clinics of North America|February 9, 2020
Extrahepatic Manifestations of Nonalcoholic Fatty Liver DiseaseJulia Wattacheril
Hepatology (Baltimore, Md.)|October 6, 2012
Nonalcoholic fatty liver disease (NAFLD): is it really a serious condition?Julia Wattacheril, Naga Chalasani
Frontline Gastroenterology|October 26, 2020
Non-alcoholic fatty liver disease (NAFLD) in non-obese individualsMeaghan Phipps, Julia Wattacheril
Clinical Liver Disease|June 13, 2019
Management of nonalcoholic fatty liver disease: Role of bariatric surgeryJulia Wattacheril, Naga Chalasani
The American Journal of Gastroenterology|February 4, 2021
Response to BraillonMeaghan Phipps, Julia Wattacheril,
Clinical Liver Disease|July 24, 2019
Julia Wattacheril, Naga Chalasani
Current Hepatology Reports|September 27, 2016
Lean NAFLD: An Underrecognized OutlierJulia Wattacheril, Arun J Sanyal
Annual Review of Pharmacology and Toxicology|October 24, 2017
Nonalcoholic Steatohepatitis (NASH) and Hepatic Fibrosis: Emerging TherapiesJulia Wattacheril, Danny Issa, Arun Sanyal
Clinical Liver Disease|June 17, 2021
Health Disparities in Screening, Diagnosis, and Treatment of Hepatocellular CarcinomaAverill Guo, Sydney Pomenti, Julia Wattacheril
Expert Opinion on Drug Safety|June 23, 2017
Treatment options for nonalcoholic steatohepatitis - a safety evaluationDanny Issa, Julia Wattacheril, Arun J Sanyal
Pageof 4